Adipose tissue hypoxia and low-grade inflammation: A possible mechanism for ethanol-related glucose intolerance?

British Journal of Nutrition

Volumn 113, Issue 9, 2015, Pages 1355-1364

  He, Zhen ^a   Li, Min ^a   Zheng, Dongmei ^a   Chen, Qing ^a   Liu, Wenwen ^a   Feng, Li ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Adipose tissue; Ethanol; Glucose intolerance; Hypoxia; Inflammation

Indexed keywords

ADIPOCYTOKINE; ALCOHOL; GLUCOSE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; WATER; SLC2A1 PROTEIN, MOUSE; SLC2A1 PROTEIN, RAT; VASCULOTROPIN A;

ADIPOCYTE; ADIPOSE TISSUE; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; EPIDIDYMIS FAT; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFLAMMATION; INTRAABDOMINAL FAT; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PERIRENAL FAT; RANDOMIZATION; RAT; WISTAR RAT; ANIMAL; CELL HYPOXIA; CELL LINE; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; EPIDIDYMIS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; MOUSE;

RATTUS; RATTUS NORVEGICUS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL HYPOXIA; CELL LINE; DIABETES MELLITUS, TYPE 2; EPIDIDYMIS; ETHANOL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; LEPTIN; LIPID METABOLISM; MALE; MICE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929737079     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451500077X     Document Type: Article

References (65)

1. Hodge AM, Dowse GK, Collins VR, et al. (1993) Abnormal glucose tolerance and alcohol consumption in three populations at high risk of non-insulin-dependent diabetes mellitus. Am J Epidemiol 137, 178-189.
2. Risinger FO & Cunningham CL (1992) Genetic differences in ethanol-induced hyperglycemia and conditioned taste aversion. Life Sci 50, Pl113-Pl118.
3. Feng L, Song YF, Guan QB, et al. (2010) Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes. Acta Pharmacol Sin 31, 329-340.
4. Markowski DN, Thies HW, Gottlieb A, et al. (2013) HMGA2 expression in white adipose tissue linking cellular senescence with diabetes. Genes Nutr 8, 449-456.
5. Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355.
6. Trayhurn P & Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60, 329-339.
7. Rajala MW & Scherer PE (2003) Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773.
8. Kershaw EE & Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556.
9. Rosen ED & Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853.
10. Skurk T, Alberti-Huber C, Herder C, et al. (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92, 1023-1033.
11. Helmlinger G, Yuan F, Dellian M, et al. (1997) Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3, 177-182.
12. Trayhurn P, Wang B & Wood IS (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100, 227-235.
13. Hosogai N, Fukuhara A, Oshima K, et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911.
14. Wang B, Wood IS & Trayhurn P (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455, 479-492.
15. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444, 860-867.
16. Feng L, Gao L, Guan Q, et al. (2008) Long-term moderate ethanol consumption restores insulin sensitivity in high-fatfed rats by increasing SLC2A4 (GLUT4) in the adipose tissue by AMP-activated protein kinase activation. J Endocrinol 199, 95-104.
17. Nakano T, Kodama H & Honjo T (1994) Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098-1101.
18. Wolins NE, Quaynor BK, Skinner JR, et al. (2006) OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis. J Lipid Res 47, 450-460.
19. Dandona P, Aljada A & Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25, 4-7.
20. Bell RA, Mayer-Davis EJ, Martin MA, et al. (2000) Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 23, 1630-1636.
21. Cooper DE, Goff DC Jr, Bell RA, et al. (2002) Is insulin sensitivity a causal intermediate in the relationship between alcohol consumption and carotid atherosclerosis?: the insulin resistance and atherosclerosis study. Diabetes Care 25, 1425-1431.
22. Dixon JB, Dixon ME & O'Brien PE (2002) Alcohol consumption in the severely obese: relationship with the metabolic syndrome. Obes Res 10, 245-252.
23. Goude D, Fagerberg B & Hulthe J (2002) Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men (AIR study). Clin Sci (Lond) 102, 345-352.
24. Zilkens RR, Burke V, Watts G, et al. (2003) The effect of alcohol intake on insulin sensitivity in men: a randomized controlled trial. Diabetes Care 26, 608-612.
25. Feng L, Han B, Wang R, et al. (2012) The frequency of daily ethanol consumption influences the effect of ethanol on insulin sensitivity in rats fed a high-fat diet. Br J Nutr 107, 850-857.
26. Boyd KN, Kumar S, O'Buckley TK, et al. (2010) Ethanol induction of steroidogenesis in rat adrenal and brain is dependent upon pituitary ACTH release and de novo adrenal StAR synthesis. J Neurochem 112, 784-796.
27. Srivastava VK, Hiney JK, Dearth RK, et al. (2001) Acute effects of ethanol on steroidogenic acute regulatory protein (StAR) in the prepubertal rat ovary. Alcohol Clin Exp Res 25, 1500-1505.
28. Khisti RT, Kumar S & Morrow AL (2003) Ethanol rapidly induces steroidogenic acute regulatory protein expression and translocation in rat adrenal gland. Eur J Pharmacol 473, 225-227.
29. Wan Q, Liu Y, Guan Q, et al. (2005) Ethanol feeding impairs insulin-stimulated glucose uptake in isolated rat skeletal muscle: role of Gs alpha and cAMP. Alcohol Clin Exp Res 29, 1450-1456.
30. He L, Marecki JC, Serrero G, et al. (2007) Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health. Mol Endocrinol 21, 2541-2550.
31. Smith KJ, Butler TR & Prendergast MA (2013) Ethanol impairs microtubule formation via interactions at a microtubule associated protein-sensitive site. Alcohol 47, 539-543.
32. Szabo G, Puppolo M, Verma B, et al. (1994) Regulatory potential of ethanol and retinoic acid on human monocyte functions. Alcohol Clin Exp Res 18, 548-554.
33. Yasmin E, Balen AH & Barth JH (2013) The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 166, 173-177.
34. Kang SW, Kim MS, Kim HS, et al. (2013) Celastrol attenuates adipokine resistin-associated matrix interaction and migration of vascular smooth muscle cells. J Cell Biochem 114, 398-408.
35. Tkacova R, Ukropec J, Skyba P, et al. (2013) Effects of hypoxia on adipose tissue expression of NFκB, IκBα, IKKγ and IKAP in patients with chronic obstructive pulmonary disease. Cell Biochem Biophys 66, 7-12.
36. McGown C, Birerdinc A & Younossi ZM (2014) Adipose tissue as an endocrine organ. Clin Liver Dis 18, 41-58.
37. Oda E (2008) The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31, 1283-1291.
38. Bremer AA & Jialal I (2013) Adipose tissue dysfunction in nascent metabolic syndrome. J Obes 2013, 393192.
39. Fox CS, Massaro JM, Hoffmann U, et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39-48.
40. Vadstrup ES, Petersen L, Sorensen TI, et al. (2003) Waist circumference in relation to history of amount and type of alcohol: results from the Copenhagen City Heart Study. Int J Obes Relat Metab Disord 27, 238-246.
41. Lukasiewicz E, Mennen LI, Bertrais S, et al. (2005) Alcohol intake in relation to body mass index and waist-to-hip ratio: the importance of type of alcoholic beverage. Public Health Nutr 8, 315-320.
42. Wannamethee SG, Shaper AG & Whincup PH (2005) Alcohol and adiposity: effects of quantity and type of drink and time relation with meals. Int J Obes (Lond) 29, 1436-1444.
43. Laitinen J, Pietilainen K, Wadsworth M, et al. (2004) Predictors of abdominal obesity among 31-y-old men and women born in Northern Finland in 1966. Eur J Clin Nutr 58, 180-190.
44. Schroder H, Morales-Molina JA, Bermejo S, et al. (2007) Relationship of abdominal obesity with alcohol consumption at population scale. Eur J Nutr 46, 369-376.
45. Freemantle N, Holmes J, Hockey A, et al. (2008) How strong is the association between abdominal obesity and the incidence of type 2 diabetes? Int J Clin Pract 62, 1391-1396.
46. Ezenwaka CE, Okoye O, Esonwune C, et al. (2014) High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition. Metab Syndr Relat Disord 12, 277-282.
47. Wang Y, Rimm EB, Stampfer MJ, et al. (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81, 555-563.
48. Greenfield JR, Samaras K, Jenkins AB, et al. (2003) Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator? Diabetes Care 26, 2734-2740.
49. Hodson L, Humphreys SM, Karpe F, et al. (2013) Metabolic signatures of human adipose tissue hypoxia in obesity. Diabetes 62, 1417-1425.
50. Varma V, Yao-Borengasser A, Bodles AM, et al. (2008) Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57, 432-439.
51. Pradhan AD, Manson JE, Rifai N, et al. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
52. Devaraj S, Dasu MR & Jialal I (2010) Diabetes is a proinflammatory state: a translational perspective. Expert Rev Endocrinol Metab 5, 19-28.
53. Festa A, D'Agostino R Jr, Howard G, et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 42-47.
54. Tanko LB & Christiansen C (2006) Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy. Climacteric 9, 169-180.
55. Kern PA, Ranganathan S, Li C, et al. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280, E745-E751.
56. Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60, 349-356.
57. Fernandez-Real JM & Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24, 278-301.
58. Winkler G, Kiss S, Keszthelyi L, et al. (2003) Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149, 129-135.
59. Yla-Herttuala S, Rissanen TT, Vajanto I, et al. (2007) Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49, 1015-1026.
60. Basak S & Hoffmann A (2008) Crosstalk via the NF-κB signaling system. Cytokine Growth Factor Rev 19, 187-197.
61. Thangarajah H, Yao D, Chang EI, et al. (2009) The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 106, 13505-13510.
62. Lopez-Jaramillo P, Gomez-Arbelaez D, Lopez-Lopez J, et al. (2014) The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Investig 18, 37-45.
63. Girman CJ, Rhodes T, Mercuri M, et al. (2004) The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93, 136-141.
64. Solymoss BC, Bourassa MG, Campeau L, et al. (2004) Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 93, 159-164.
65. Ganguly A & Devaskar SU (2008) Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance. Am J Physiol Endocrinol Metab 294, E1144-E1151.